"signal loss > 20% (1.5 T) or > 25% (3 T) between in-phase and out-of-phase imaging is considered to indicate normal marrow or benign conditions (e.g. red marrow conversion, FNMH, osseous haemangioma, and bone marrow oedema) 4"
"signal loss > 20% (1.5 T) or > 25% (3 T) between in-phase and out-of-phase imaging is considered to indicate normal marrow or benign conditions (e.g. red marrow conversion, FNMH, osseous haemangioma, and bone marrow oedema) 4"
"No uniform term is used in the literature to describe this imaging finding, additional terms include vertebral marrow signal abnormality and abnormal bone marrow signal 1,2."
"No uniform term is used in the literature to describe this imaging finding, additional terms include vertebral marrow signal abnormality and abnormal bone marrow signal 1,2."
"No uniform term is used in the literature to describe this imaging finding, additional terms include vertebral marrow signal abnormality and abnormal bone marrow signal 1,2."
"signal loss > 20% (1.5 T) or > 25% (3 T) between in-phase and out-of-phase imaging is considered to indicate normal marrow or benign conditions (e.g. red marrow conversion, FNMH, osseous haemangioma, and bone marrow oedema) 4"
"Heterogeneous bone marrow signal imaging features are not well defined and rely on the subjective impression of the radiologist 1,2. Various patterns have been described including, focal, diffuse, combined diffuse and focal, multifocal, variegated, and normal 1,3."
"There is no consensus recommendations for the work-up of heterogeneous bone marrow signal with variable recommendations 1. Patients are often referred to oncology or other specialties, where work-ups performed include further imaging, laboratory investigations, and bone marrow or other biopsies 1,2."